China Pharma Holdings (CPHI) Gross Profit (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly Gross Profit came in at $285487.0 in Q1 2026, up 309.82% YoY from $69661.1 in Q1 2025, and up 89.35% on a QoQ basis from $150775.0 in Q4 2025.
China Pharma Holdings (CPHI) Gross Profit (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 17 years of Gross Profit data on file, last reported at $285487.0 in Q1 2026.
- Quarterly Gross Profit rose 309.82% year-over-year to $285487.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $289598.0 (up 115.81% YoY) and the FY2025 annual result came in at -$131950.0, up 93.35% from the prior year.
- Gross Profit rose to $285487.0 in Q1 2026, from $150775.0 in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $285487.0 in Q1 2026 to a low of -$1.0 million in Q2 2024.
- A 5-year average of -$153359.5 and a median of -$137756.0 in 2022 frame the typical range for Gross Profit.
- Annual changes were most pronounced in 2024 — Gross Profit sank 592.34% — and 2026, when it jumped 309.82%.
- Tracing CPHI's Gross Profit over 5 years: stood at $42682.0 in 2022, then sank by 285.46% to -$79158.0 in 2023, then tumbled by 102.87% to -$160589.0 in 2024, then surged by 193.89% to $150775.0 in 2025, then jumped by 89.35% to $285487.0 in 2026.
- The last three Gross Profit figures came in at $285487.0 (Q1 2026), $150775.0 (Q4 2025), and -$59654.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | China Pharma Holdings | 42.13 Mn | 41.82 Mn | 83,566.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 285,487.00 |
| Mar 31, 2026 | 285,487.00 |
| Dec 31, 2025 | 150,775.00 |
| Dec 31, 2025 | 150,775.00 |
| Sep 30, 2025 | -59,654.00 |
| Sep 30, 2025 | -59,654.00 |
| Jun 30, 2025 | -87,010.00 |
| Jun 30, 2025 | -87,010.00 |
| Mar 31, 2025 | -136,061.00 |
| Mar 31, 2025 | -136,061.00 |
| Dec 31, 2024 | -160,589.00 |
| Dec 31, 2024 | -160,589.00 |
| Sep 30, 2024 | -519,649.00 |
| Sep 30, 2024 | -519,649.00 |
| Jun 30, 2024 | -1.02 Mn |
| Jun 30, 2024 | -1.02 Mn |
| Mar 31, 2024 | -290,024.00 |
| Mar 31, 2024 | -290,024.00 |
| Dec 31, 2023 | -79,158.00 |
| Dec 31, 2023 | -79,158.00 |